United States · FDA National Drug Code directory
Lamotrigine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 46708-277_c0f1f48a-19e7-4d18-a28e-c20531d83db7
- Product NDC
- 46708-277
- Form
- TABLET
- Composition / generic term
- Lamotrigine
- Labeler
- Alembic Pharmaceuticals Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20130101
- Source listing expiry
- 20271231
Source-listed ingredients
- LAMOTRIGINE — 200 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET in 1 BOTTLE (46708-277-30) · 46708-277-30
- 100 TABLET in 1 BOTTLE (46708-277-31) · 46708-277-31
- 60 TABLET in 1 BOTTLE (46708-277-60) · 46708-277-60
- 1000 TABLET in 1 BOTTLE (46708-277-91) · 46708-277-91
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →